L. Richeldi (Modena, Italy), J. J. G. Egan (Dublin, Ireland), K. Antoniou (Heraklion, Greece), D. Israel-Biet (Paris, France)
Preliminary results of the French national prospective cohort on IPF
H. Nunes, Z. Carton, V. Cottin, D. Israel-Biet, M. Brauner, M. Kambouchner, B. Crestani, J. Cadranel, B. Wallaert, G. Prévot, K. Juvin, R. Borie, M. Wislez, J. Chabrol, A. Gaudouin, S. Feuillet, F. Gagnadoux, S. Marchand-Adam, B. Maître, P. Bonniaud, P. Delaval, J. F. Cordier, D. Valeyre (Bobigny, Lyon, Paris, Lille, Toulouse, Besançon, Angers, Tours, Creteil, Dijon, Rennes, France)
|  |
Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF)
S. Avdeev, M. Makarova, A. Chuchalin (Moscow, Russian Federation)
| |
Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome
C. Probst, E. Bargagli, P. Rottoli, F. Kollert, K. Höhne, G. Zissel, J. Müller-Quernheim, A. Prasse (Freiburg, Germany; Siena, Italy)
| |
Risk factors of acute exacerbation of idiopathic pulmonary fibrosis-extended analysis of the pirfenidone trial in Japan
H. Taniguchi, Y. Kondoh, M. Ebina, A. Azuma, T. Ogura, M. Suga, Y. Taguchi, H. Takahashi, K. Nakata, A. Sato, Y. Sugiyama, S. Kudoh, T. Nukiwa (Seto, Sendai, Tokyo, Yokohama, Kumamoto, Tenri, Sapporo, Kyoto, Tochigi, Japan)
| |
Clinical profile of idiopathic pulmonary fibrosis with lung cancer
C. Gurioli, S. Tomassetti, C. Ravaglia, M. Romagnoli, G. Casoni, N. Sverzellati, M. Zompatori, M. Chilosi, V. Poletti (Forli‘, Parma, Bologna, Verona, Italy)
|  |
Effects of nitric oxide synthase up-regulation in early remodeling of usual interstitial pneumonia has impact on long term outcome of patients
E. R. Parra, A. Aguiar Junior, S. Fernezlian, V. Capelozzi (São Paulo, Brazil)
| |
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
D. Smadja, L. Mauge, H. Nunes, C. d‘Audigier, K. Juvin, R. Borie, Z. Carton, O. Sanchez, B. Crestani, D. Valeyre, P. Gaussem, D. Israel-Biet (Paris, Bobigny, France)
| |
Leptin and adiponectin levels in idiopathic pulmonary fibrosis
F. Malli, P. Georgoulias, V. Varvara, I. Tsilioni, K. Gourgoulianis, Z. Daniil (Larissa, Greece)
| |
HRCT score to control and evaluate the prognosis in idiopathic pulmonary fibrosis
R. Peris, E. Fernandez-Fabrellas, I. Inchaurraga, M. L. Domingo, J. Palop, R. Blanquer (Valencia, Spain)
| |
Daily hand-held spirometry for the monitoring of patients with idiopathic pulmonary fibrosis
A. M. Russell, P. Lukey, U. Fraser, E. Renzoni, A. Wells, T. Maher (London, Stevenage, United Kingdom)
| |
Slow versus rapid progressors in idiopathic pulmonary fibrosis
F. Soares Pires, C. Damas, P. Mota, N. Melo, D. Costa, J. M. Jesus, C. Souto-Moura, A. Morais (Porto, Portugal)
| |
Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009
A. Buraczewska, W. Skorupa, J. Kus, A. Kempisty, I. Bartoszuk (Warsaw, Poland)
| |
Prognostic evaluation in idiopathic pulmonary fibrosis (IPF)
O. Munteanu, V. Botnaru, D. Chesov (Chisinau, Republic Of Moldova)
| |
The prognostic significance of cardiopulmonary exercise in IPF
C. Triantafillidou, P. Lyberopoulos, L. Kolilekas, K. Kagouridis, S. Gyftopoulos, C. Sotiropoulou, A. Kotanidou, A. Karakatsani, S. Papiris (Athens, Greece)
| |
Proposal for revised clasification of disease severity of idiopathic pulmonary fibrosis in Japan
H. Taniguchi, K. Kataoka, Y. Kondoh, S. Homma, M. Mishima, Y. Inoue, T. Ogura, M. Bando, K. Hagiwara, H. Takahashi, K. Chida, K. Kishi, Y. Sugiyama (Seto, Tokyo, Kyoto, Osaka, Yokohama, Tochigi, Saitama, Sapporo, Hamamatsu, Japan)
| |
Therapeutic effect of combination of salvia and ligustrazine on bleomycin-induced pulmonary fibrosis
X. Fan, W. Wang, Y. Chen (Luzhou, China)
| |
Promising effect of PMX-DHP absorption therapy for acute exacerbation of IPF
A. Azuma, S. Abe, T. Ogura, H. Mukae, H. Taniguchi, M. Bando, Y. Sugiyama (Tokyo, Yokohama, Kitakyushu, Seto, Shimotsuke, Japan)
| |
Effect of bosentan on MMP-7 levels as add-on therapy in idiopathic pulmonary fibrosis. A prospective study
K. Samara, E. Vassalou, I. Giannarakis, I. Lasithiotaki, N. Tzanakis, N. Siafakas, K. Antoniou (Heraklion, Greece)
| |
Tolerance of pirfenidone in Indian patients with idiopathic pulmonary fibrosis – Usual interstial pneumonitis: An initial experience
P. Chaudhari, A. Kate, J. Leuppi, P. Chhajed (Mumbai, NaviMumbai, India)
| |
Correlations of quantitative HRCT score in idiopathic pulmonary fibrosis (IPF)
O. Munteanu, V. Botnaru, D. Calaras (Chisinau, Republic Of Moldova)
| |